EyePoint (EYPT) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on EyePoint (EYPT) is Moderate Underperform.

The composite score behind that read is -0.33, weighing +0.18 of bullish evidence against -0.52 bearish.

EyePoint last closed at $3.40, -1.73% on the session.

Against the IVW growth benchmark the position is -2.53% over the forecast window.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

20 graded predictions for EYPT so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks EyePoint in the 8th percentile on return on equity, where 100 is best.

EyePoint is classified under Health Care / Pharmaceuticals, with a market capitalisation of $298.29M.

StockMap tracks EyePoint as the 86th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite EyePoint ranks 134th of 151 in the group, against a group median of -0.08.